News

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Trending tickers: Novo Nordisk, Starbucks, SoFi Technologies, BAE Systems and Taylor Wimpey

In a release on Tuesday, Novo Nordisk cut its expected full-year sales growth to 8%-14%, down from the 13%-21% it had ...
The Business Times1d

Europe: Stocks close up; Novo Nordisk logs its biggest daily drop on record

EUROPEAN stocks closed higher on Tuesday, buoyed by financials and defence stocks, though Danish stocks logged their biggest ...

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

Novo’s CEO Shake-Up: Can an Insider Reverse Wegovy’s Slide?

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
NDTV Profit1d

Novo Falls By Record As Wegovy Slumps And Insider Named CEO

The appointment came shortly after Novo slashed its financial forecast, predicting this year’s sales will grow 8% to 14%, ...
24/7 Wall St.7mon

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (July 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Novo Nordisk projects weaker sales as it battles copycat drugs

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...